Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With Hypertension

ClinicalTrials.gov ID: NCT00273052

Public ClinicalTrials.gov record NCT00273052. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 5:48 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Phosphate Modified Release Formulation (COREG- MR) With Metoprolol Succinate (TOPROL XL) on the Lipid Profile in Normolipidemic, or Mildly Dyslipidemic Hypertensive Patients

Study identification

NCT ID
NCT00273052
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
514 participants

Conditions and interventions

Conditions

Interventions

  • Carvedilol Phosphate modified release formulation Drug
  • metoprolol succinate Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 4, 2006
Primary completion
Nov 30, 2007
Completion
Dec 27, 2007
Last update posted
Jun 24, 2018

2006 – 2007

United States locations

U.S. sites
102
U.S. states
33
U.S. cities
87
Facility City State ZIP Site status
GSK Investigational Site Birmingham Alabama 35205
GSK Investigational Site Birmingham Alabama 35209
GSK Investigational Site Birmingham Alabama 35211
GSK Investigational Site Birmingham Alabama 35242
GSK Investigational Site Montgomery Alabama 36106
GSK Investigational Site Chandler Arizona 85224
GSK Investigational Site Mesa Arizona 85201
GSK Investigational Site Phoenix Arizona 85014
GSK Investigational Site Phoenix Arizona 85029
GSK Investigational Site Tucson Arizona 85723
GSK Investigational Site Tucson Arizona 85741
GSK Investigational Site Fayetteville Arkansas 72701
GSK Investigational Site Little Rock Arkansas 72205
GSK Investigational Site Carmichael California 95608
GSK Investigational Site Healdsburg California 95448
GSK Investigational Site Irvine California 92618
GSK Investigational Site La Jolla California 92037
GSK Investigational Site Los Angeles California 90057
GSK Investigational Site Los Angeles California 90502
GSK Investigational Site Mission Viejo California 92691
GSK Investigational Site Poway California 92064
GSK Investigational Site Sacramento California 95816
GSK Investigational Site San Diego California 92177
GSK Investigational Site Spring Valley California 91978
GSK Investigational Site Stockton California 95204
GSK Investigational Site Torrance California 90503
GSK Investigational Site Vista California 92084
GSK Investigational Site Avon Connecticut 06001
GSK Investigational Site Altamonte Springs Florida 32714
GSK Investigational Site Clearwater Florida 33755
GSK Investigational Site Fort Lauderdale Florida 33308
GSK Investigational Site Jacksonville Florida 32205
GSK Investigational Site Jacksonville Florida 32216
GSK Investigational Site Jacksonville Florida 32259
GSK Investigational Site Pembroke Pines Florida 33024
GSK Investigational Site Atlanta Georgia 30308
GSK Investigational Site Marietta Georgia 30067
GSK Investigational Site Roswell Georgia 30076
GSK Investigational Site Aurora Illinois 60504
GSK Investigational Site Chicago Illinois 60611
GSK Investigational Site Gillespie Illinois 62033
GSK Investigational Site Vernon Hills Illinois 60061
GSK Investigational Site Evansville Indiana 47714
GSK Investigational Site Indianapolis Indiana 46260
GSK Investigational Site Wichita Kansas 67205
GSK Investigational Site Wichita Kansas 67214
GSK Investigational Site Bossier City Louisiana 71111
GSK Investigational Site Auburn Maine 04210
GSK Investigational Site Natick Massachusetts 01760
GSK Investigational Site Taunton Massachusetts 02780.
GSK Investigational Site West Yarmouth Massachusetts 02673
GSK Investigational Site Detroit Michigan 48235
GSK Investigational Site Brooklyn Center Minnesota 55430
GSK Investigational Site Olive Branch Mississippi 38654
GSK Investigational Site Springfield Missouri 65807
GSK Investigational Site St Louis Missouri 63141
GSK Investigational Site Omaha Nebraska 68134
GSK Investigational Site Omaha Nebraska 68144
GSK Investigational Site Henderson Nevada 89014
GSK Investigational Site Las Vegas Nevada 89119
GSK Investigational Site Las Vegas Nevada 89128
GSK Investigational Site Brick New Jersey 08724
GSK Investigational Site Elizabeth New Jersey 07202
GSK Investigational Site Albuquerque New Mexico 87102
GSK Investigational Site Albuquerque New Mexico 87108
GSK Investigational Site East Syracuse New York 13057
GSK Investigational Site Endwell New York 13760
GSK Investigational Site Fishkill New York 12524
GSK Investigational Site New York New York 10016
GSK Investigational Site New York New York 10021
GSK Investigational Site Charlotte North Carolina 28207
GSK Investigational Site Raleigh North Carolina 27612
GSK Investigational Site Statesville North Carolina 28625
GSK Investigational Site Wilmington North Carolina 28401
GSK Investigational Site Winston-Salem North Carolina 27103
GSK Investigational Site Cincinnati Ohio 45245
GSK Investigational Site Cincinnati Ohio 45246
GSK Investigational Site Cleveland Ohio 44195
GSK Investigational Site Kettering Ohio 45429
GSK Investigational Site Oklahoma City Oklahoma 73112
GSK Investigational Site Erie Pennsylvania 16508
GSK Investigational Site Warminster Pennsylvania 18974
GSK Investigational Site West Chester Pennsylvania 19380
GSK Investigational Site Columbia South Carolina 29201
GSK Investigational Site Greer South Carolina 29651
GSK Investigational Site Hartsville South Carolina 29550
GSK Investigational Site Simpsonville South Carolina 29681
GSK Investigational Site Bristol Tennessee 37620
GSK Investigational Site Kingsport Tennessee 37660
GSK Investigational Site Corpus Christi Texas 78404
GSK Investigational Site San Antonio Texas 78237
GSK Investigational Site San Antonio Texas 78258
GSK Investigational Site Salt Lake City Utah 84109
GSK Investigational Site Burke Virginia 22015
GSK Investigational Site Galax Virginia 24333
GSK Investigational Site Manassas Virginia 22015
GSK Investigational Site Newport News Virginia 23606
GSK Investigational Site Richmond Virginia 23294
GSK Investigational Site Springfield Virginia 22151
GSK Investigational Site Virginia Beach Virginia 23451
GSK Investigational Site Walla Walla Washington 99362
GSK Investigational Site Lewisburg West Virginia 24901

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00273052, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 24, 2018 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00273052 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →